Showing results (1951-1960 of 2,185) with videos related to

Sort By:
Pageof 219
Frontiers in Oncology|November 15, 2023
Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrenceWilliam Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
Cancers|April 27, 2024
Investigating the Role of SNAI1 and ZEB1 Expression in Prostate Cancer Progression and Immune Modulation of the Tumor MicroenvironmentWilliam Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohortsStephanie A Harmon, Palak G Patel, Thomas H Sanford, et al.
European Journal of Medical Genetics|September 15, 2010
Cytogenetic molecular delineation of a terminal 18q deletion suggesting neo-telomere formationLeslie Domenici Kulikowski, Maisa Yoshimoto, Fernanda Teixeira da Silva Bellucco, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 3, 2010
Skeletal muscle dysfunction in muscle-specific LKB1 knockout miceDavid M Thomson, Chad R Hancock, Bradley G Evanson, et al.
The EMBO Journal|September 3, 2004
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrityJohn Peter McPherson, Laura Tamblyn, Andrew Elia, et al.
International Journal of Environmental Research and Public Health|May 14, 2022
Achieving Minimum Standards for Infection Prevention and Control in Sierra Leone: Urgent Need for a Quantum Leap in Progress in the COVID-19 Era!Bobson Derrick Fofanah, Arpine Abrahamyan, Anna Maruta, et al.
Bioorganic & Medicinal Chemistry|June 30, 2022
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophyMaria Chatzopoulou, Daniel Conole, Enrico Emer, et al.
Pageof 219